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Purpose: Obstructive sleep apnea (OSA) is considered an independent risk factor 
for hypertension. However, it is still not clear which clinical factors are related with 
the presence of hypertension in OSA patients. We aimed to find different physical 
features and compare the sleep study results which are associated with the occur-
rence of hypertension in OSA patients. Materials and Methods: Medical records 
were retrospectively reviewed for patients diagnosed with OSA at Severance Cardio-
vascular Hospital between 2010 and 2013. Males with moderate to severe OSA pa-
tients were enrolled in this study. Clinical and polysomnographic features were eval-
uated to assess clinical variables that are significantly associated with hypertension 
by statistical analysis. Results: Among men with moderate to severe OSA, age was 
negatively correlated with hypertension (odds ratio=0.956), while neck circumfer-
ence was positively correlated with the presence of hypertension (odds ratio=1.363). 
Among the polysomnographic results, the lowest O2 saturation during sleep was sig-
nificantly associated with the presence of hypertension (odds ratio=0.900). Conclu-
sion: Age and neck circumference should be considered as clinically significant fea-
tures, and the lowest blood O2 saturation during sleep should be emphasized in 
predicting the coexistence or development of hypertension in OSA patients.
Key Words:   Sleep apnea, hypertension, polysomnography, neck circumference, 
lowest oxygen saturation level
INTRODUCTION
Obstructive sleep apnea (OSA) is commonly associated with hypertension, and the 
main pathophysiologic mechanism for the blood pressure-elevating effect of OSA 
is the increased sympathetic activity that influences vascular resistance and cardiac 
output.1 Other features such as a pro-inflammatory effect, increased oxidative stress, 
and increased vascular stiffness are also suggested mechanisms that influence the 
increased risk of hypertension in OSA patients.1 Additionally, blood pressure con-
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suggest useful predictors that might be helpful in early di-
agnosis of un-identified hypertension in OSA patients. 
MATERIALS AND METHODS
　　　
Study population
This study was approved by the Institutional Review Board 
of Yonsei University College of Medicine (IRB No. 4-2014-
0132). Medical records were retrospectively reviewed for pa-
tients diagnosed with OSA based on validated, ambulatory 
unattended polysomnography (Embletta ×100)16 performed 
at Severance Hospital between 2010 and 2013. Only male 
patients were enrolled because the characteristics of OSA in 
women and results in men are more heterogenous.17 As such, 
for subjects with asymptomatic obstructive sleep apnea, 
polysomnography was performed as an etiologic and risk 
factor assessment in hypertensives, atrial fibrillation and in 
patients with coronary artery disease. Patients completed the 
polysomnography examination, the Epworth Sleepiness 
Score (ESS) questionnaire to assess daytime sleepiness and 
the blood tests for lipid profiles and fasting glucose level. 
Male patients whose apnea/hypopnea index (AHI) was more 
than 15 (total 183 patients) were enrolled in this study. Office 
blood pressure was measured twice either with a mercury 
sphygmomanometer or an aneroid sphygmomanometer 
(Welch Allyn Silver Series DS45, Skaneateles Falls, NY, 
USA) and the average value was used. The patients were 
grouped as hypertension if they are diagnosed hypertension 
based on blood pressure following current guidelines pub-
lished by the European Society of Hypertension18 or they are 
currently taking blood pressure lowering medications. The 
patients who do not belong to above category were grouped 
as non-hypertensives. Other past medical histories of en-
rolled patients were not considered in our study. Participants 
were excluded if they had sleep studies with un-interpretable 
measurements, inadequate sleep duration, missed physical 
measurements or lack of any laboratory result.
Anthropometric measurements
Anthropometric characteristics were measured by one skilled 
examiner according to standardized methods. Height was 
measured without shoes from the top of the head to the end of 
the first toe. Neck circumference (NC) was measured using a 
flexible ruler at the thyroid cartilage level. Waist circumfer-
ence was measured at the midway point between the lowest 
portion of the rib cage and the iliac crest. Hip circumference 
trol is critical because of its effect on cardiovascular morbidi-
ty and mortality.2,3 OSA is known as a secondary cause of 
hypertension but also independently associated with target-
organ damage by sympathetic overactivity in patients having 
hypertension.4,5 Recently, the role of nocturnal rostral fluid 
shift in the pathogenesis of OSA has been raised and OSA 
can be aggravated through increase of pharyngeal resistance 
induced by co-existing hypertension.6,7 Therefore, early diag-
nosis of hypertension in OSA patients is very important.
In a previous study, patients who have hypertension or 
OSA were reported to have higher prevalence of diabetes 
mellitus, metabolic syndrome, and dyslipidemia (including 
low level of high density lipoprotein and high level of tri-
glyceride).8-11 They also had distinguishing physical charac-
teristics such as increased body mass index (BMI), neck 
circumference, and abdominal circumference compared to 
control.4 In another study, age, sex, BMI, and family history 
of hypertension were representatively different between 
OSA patients with hypertension and OSA patients having 
normal blood pressure.12 Although OSA is now thought to 
be an independent risk factor of hypertension, the charac-
teristics associated with hypertension in patients with OSA 
are heterogenous and studies are still insufficient.
Many clinicians have focused on the influence of gender 
differences on the occurrence of hypertension in OSA pa-
tients. The Western New York Health Study reported a 66% 
higher prevalence of hypertension among women with sub-
jective symptoms but subjective symptoms were not associ-
ated with the prevalence of hypertension among male pa-
tients.13 This association was independent of socioeconomic 
status, traditional cardiovascular risk factors, and psychiat-
ric comorbidities.13 In another study, age was not signifi-
cantly associated with the occurrence of hypertension in pa-
tients who reported a short duration of sleep.14 Obesity, 
especially visceral obesity, contributes to the pathogenesis 
of hypertension in OSA patients.15 The results from previ-
ous reports have suggested many factors that are associated 
with hypertension in OSA patients. However, the conclu-
sions are inconsistent and the association between the clini-
cal characteristics of patients with hypertension and de-
tailed polysomnographic data has not been reported. We 
aimed to find different clinical characteristics and the fac-
tors of sleep study between OSA patients who are hyper-
tensive and OSA patients who have normal blood pressure. 
Lipid profile and fasting glucose level were also included in 
the analysis because of high prevalence of metabolic syn-
drome in OSA patients.11 Based on these results, we tried to 
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analyzed in this study. The mean ages were 60.70±9.27 years 
for the non-HTN group and 53.26±12.73 years for the HTN 
group (p<0.001). HTN group patients were more obese, 
which was represented by increased body weight and high 
level of BMI. BMI was 25.18±3.04 in non-HTN group and 
27.12±3.55 in HTN group (p<0.001). Neck circumference 
was 38.45±2.19 cm in non-HTN group and 40.27±2.71 cm 
in HTN group showing meaningful difference (p<0.001). 
Central obesity-related physical factors such as waist 
(93.08±8.58 cm in non-HTN group and 96.86±8.83 cm in 
HTN group) and hip circumferences (97.87±6.41 cm in non-
HTN group and 103.02±10.33 cm in HTN group) were also 
significantly different between two groups (p<0.001).
The basal blood laboratory tests revealed that the TG lev-
el was the only different factor which was 127.17±73.31 
mg/dL in non-HTN group and 167.26±123.81 mg/dL in 
HTN group (Table 1). The HDL, LDL and fasting glucose 
level were not significantly different.
Age, weight, NC, waist and hip circumferences, and TG 
levels (p<0.05) which were statistically different between 
the non-HTN and HTN groups were selected and further 
evaluated by univariate and multivariate logistic regression 
analysis (Table 2). Age was negatively (OR=0.956) and NC 
was positively (OR=1.363) related to the presence of hy-
pertension, and these clinical characteristics were also sig-
nificant in multivariate analysis (p<0.05) (Fig. 1). 
Differences in polysomnographic parameters: non-
HTN vs. HTN group
Typically, the AHI is considered diagnostic for OSA. We 
was measured at the largest lateral extension of the hips.
Blood analysis
Blood samples were obtained after an overnight fast. Lipid 
profiles including total cholesterol, triglycerides (TG), high 
density lipoprotein (HDL), and low density lipoprotein 
(LDL) as well as fasting blood glucose level were measured. 
Statistics
The study population was divided into OSA patients without 
hypertension (non-HTN group; n=67) and OSA patients 
with hypertension (HTN group; n=116). For the comparison 
of continuous variables by group, two independent sample t-
tests were used. Univariate and multivariate logistic regres-
sion analyses were applied to calculate the odds ratios (OR) 
of variables. All variables with a p<0.05 in the univariate 
analysis were selected and further studied by multivariate 
logistic regression analysis. Adjusted OR with 95% confi-
dence intervals were calculated for these independent vari-
ables. Pearson correlation coefficients were calculated be-
tween variables and polysomnographic findings. All analyses 
were done using SPSS version 20 (IBM Corporation, Ar-
monk, NY, USA).
RESULTS
 
Differences in physical parameters and blood tests: 
non-HTN vs. HTN group
A total of 183 moderate to severe male OSA patients were 
Table 1. Patients Characteristics
Variables No HTN (n=67) HTN (n=116) p value
Age (yrs)   60.70±9.27     53.26±12.73 <0.001
Height (cm) 169.33±6.38 170.52±6.03 0.210 
Weight (kg)     72.28±10.16     78.98±14.80 <0.001
BMI (kg/m2)   25.18±3.04   27.12±3.55 <0.001
Neck circumference (cm)   38.45±2.19   40.27±2.71 <0.001
Waist circumference (cm)   93.03±8.58   96.86±8.83 0.005 
Hip circumference (cm)   97.87±6.41   103.02±10.33 <0.001
Cholesterol (mg/dL)   174.40±39.38   183.69±41.10 0.137 
TG (mg/dL)   127.18±73.31     167.26±123.81 0.007 
HDL (mg/dL)   45.70±9.46     46.14±17.96 0.854 
LDL (mg/dL)   102.58±31.17   106.97±36.89 0.413 
Fasting glucose (mg/dL)   109.97±28.43   111.37±27.47 0.743 
Longest apnea duration (s)     45.91±18.52     44.79±18.50 0.694 
Longest hypopnea duration (s)     58.81±17.51     60.38±20.42 0.598 
BMI, body mass index; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; HTN, hypertension.
Data are presented as mean±SD for data with normal distribution.
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considered other features, including the longest apnea/hy-
popnea duration, average O2 saturation, and lowest O2 satu-
ration and these were evaluated according to the presence 
of hypertension (Table 3). The average O2 (94.96±1.27% in 
non-HTN, 94.27±1.91% in HTN) and lowest O2 saturation 
levels (84.15±4.97% in non-HTN, 80.58±6.52% in HTN) 
were significant factors influencing the presence of hyper-
tension by the t-test. Mean AHI was also significantly dif-
ferent between two groups (29.79±11.35 in non-HTN, 
34.12±16.89 in HTN). These factors were further studied 
by univariate and multivariate analysis, and the lowest O2 
saturation level during sleep was the only significant factor 
identified in multivariate analysis (p=0.006). The OR for 
the lowest O2 saturation was 0.900, which means that as the 
lowest O2 saturation level increases, the probability of co-
existing hypertension decreases (Table 4, Fig. 2). Other fac-
tors of sleep study were not statistically meaningful in mul-
tivariate analysis. Excessive daytime sleepiness assessed by 
ESS was also not a meaningful factor. To further study the 
clinical significance of the lowest O2 saturation level during 
sleep, patients were grouped, and the correlation of clinical 
variables and the lowest O2 saturation level were compared 
(Table 5). In the HTN group, NC, BMI, and waist circumfer-
ence, were negatively correlated with the lowest O2 satura-
tion level (p<0.05); these correlations were not demonstrat-
ed in the non-HTN group. NC and waist circumference had 
the highest correlation coefficient in the HTN group (r= 
-0.276). Age was correlated with the lowest O2 saturation 
level among all patients (r=0.159, p=0.032). However, age 
did not show any significant correlation with the lowest O2 
saturation level in subgroup analysis for the HTN and non-
HTN groups. 
DISCUSSION
Growing evidence suggests that OSA is one of the major 
causes of hypertension.19,20 In our study of 183 men with 
moderate to severe OSA, 116 men had hypertension (63% 
prevalence). Recently, it was reported that portable devices 
showed good diagnostic performance compared with level 
1 sleep tests in adult patients21 and our result also shows 
that Embletta ×100 which is a level 2 portable device is 
useful in diagnosis of OSA. The prevalence of hypertension 
in OSA patients was higher compared to previous reports.22 
This may be because most of the hypertensive patients re-
ferred to Severance Hospital have severe hypertension and 
are often difficult to treat. Furthermore, the exclusion of 
mild OSA may have influenced this prevalence.
In this study, age was the most meaningful factor that 
predicted the co-existence of hypertension in OSA patients. 
Interestingly, the mean age was 7 years younger in the HTN 
group compared to the non-HTN group. Similar results 
were previously reported and the OR of hypertension de-
creased as age increased in severe OSA patients.23 Howev-
er, increased age has been positively associated with sleep-
disordered breathing,24 and a contradictory study reported 
that age had no significant association with hypertension in 
male OSA patients.13 Based on our study, middle-aged pa-
tients with an AHI >15 should be carefully evaluated for 
concurrent hypertension. However, care should be taken 
Table 2. Odds Ratio of Age, Weight, Neck Circumference, Waist, Hip, and Triglyceride for Hypertension
 Univariate OR (95% CI) p value Multivariate OR (95% CI) p value
Age (yrs) 0.945 (0.918, 0.972) <0.001 0.956 (0.919, 0.994) 0.023 
Weight (kg) 1.043 (1.015, 1.072)   0.002 0.959 (0.890, 1.032) 0.263 
Neck circumference (cm) 1.349 (1.174, 1.549) <0.001 1.363 (1.066, 1.741) 0.013 
Waist circumference (cm) 1.055 (1.016, 1.096)   0.006 0.990 (0.916, 1.071) 0.806 
Hip circumference (cm) 1.086 (1.038, 1.137) <0.001 1.040 (0.962, 1.124) 0.328 
TG (mg/dL) 1.005 (1.001, 1.009)   0.023 1.002 (0.998, 1.006) 0.262 
OR, odds ratio; CI, confidence interval; TG, triglyceride.
Fig. 1. The difference of age and neck circumference in hypertensive and 
non-hypertensive OSA patients. Data is shown as mean±SD. **Significant 
(p<0.01). N.C, neck circumference; OSA, obstructive sleep apnea.
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HTN group. When we defined obesity as BMI above 25, 
obese patients had much higher value of NC, suggesting 
the relation of obesity with neck circumference (data not 
shown). NC, one clinical characteristics related to higher 
mortality of acute ischemic stroke, has been shown to be an 
independent predictor of coronary artery disease.29,30 NC 
was identified in our study as a significant clinical character-
istic by multivariate regression analysis and was associated 
with the presence of hypertension in moderate to severe 
OSA patients. In recent studies, rostral fluid displacement in 
hypertensive patients has been linked to OSA by contribut-
ing to the narrowing of the upper airway,31,32 and NC could 
be increased by this fluid shift from the lower body.22,29,30,33,34 
This result suggests that NC should not be overlooked in 
evaluating OSA patients. Furthermore, when we plotted 
Receiver Operating Characteristic (ROC) Curve of NC to 
the presence of HTN, the value of the Area Under the ROC 
Curve was 0.693 and the cut-off value was 39.750 (data not 
shown). We suggest that the patients whose NC is more 
than 39.75 have increased risk for the presence of concur-
rent HTN.
Lipid profile and fasting glucose level were not associat-
ed with the presence of hypertension. Subjective daytime 
sleepiness estimated by the ESS was not associated with 
the incidence of hypertension, while one study reported that 
prescreening of OSA by ESS was useful in predicting post-
cardiac operative atrial fibrillation.35
AHI defines only the number of apneic or hypopneic 
events per hour. Diagnosis of OSA is based on AHI and 
when interpreting these results as there is the potential for se-
lection bias in this study. When the average BMI of younger 
(age <60 yr) and older patients (age ≥60 yr) were com-
pared, younger patients had higher BMI levels compared to 
the older patients, which might explain why age was nega-
tively correlated with hypertension. 
The prevalence of obesity in the general population is in-
creasing and becoming a significant health burden. In this 
study, several physical measures such as body weight, NC, 
waist, and hip circumferences were significantly higher 
among patients with hypertension. Although obesity and 
OSA are independently associated with hypertension, stud-
ies show they are interrelated. Obesity is an important risk 
factor for both hypertension and OSA.25-28 In our study, BMI 
in the HTN group was significantly higher than in the non-
Table 3. Multiple Variables of Polysomnography in Moderate to Severe OSA Patients with or without Hypertension 
No HTN (n=67) HTN (n=116) p value 
Longest apnea duration (s)   45.91±18.52   44.79±18.50   0.694 
Longest hypopnea duration (s)   58.81±17.51   60.38±20.42   0.598 
REM AHI (events/hr)   25.52±18.87   29.97±20.05   0.146 
NREM AHI (events/hr)   31.83±22.12   35.35±22.52   0.195 
Average O2 saturation (%) 94.96±1.27 94.27±1.91   0.009 
Lowest O2 saturation (%) 84.15±4.97 80.58±6.52 <0.001 
AHI (events/hr)   29.79±11.35   34.12±16.89  0.04 
ESS   6.81±4.39   8.00±4.70   0.092 
AHI, apnea/hypopnea index; ESS, epworth sleepiness score; REM AHI, apnea/hypopnea index in rapid eye movement sleep; NREM AHI, apnea/hypopnea 
index in non rapid eye movement sleep; OSA, obstructive sleep apnea; HTN, hypertension.
Table 4. Odds Ratio of Average and Lowest O2 Saturation and Various AHIs for Hypertension
Univariate OR (95% CI) p value Multivariate OR (95% CI) p value 
Average O2 saturation (%) 0.758 (0.612, 0.939)   0.011 1.000 (0.774, 1.292) >0.999 
Lowest O2 saturation (%) 0.897 (0.846, 0.952) <0.001 0.900 (0.834, 0.970)   0.006 
AHI (events/hr) 1.021 (0.999, 1.043)   0.067 0.974 (0.941, 1.008)   0.130 
AHI, apnea/hypopnea index; OR, odds ratio; CI, confidence interval.
Fig. 2. The difference of the lowest O2 saturation during sleep in hyperten-
sive and non-hypertensive OSA patients. Data is shown as mean±SD. 
**Significant (p<0.01). OSA, obstructive sleep apnea.
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other features reflecting the oxidative condition during sleep 
and should be considered as critical values in predicting co-
existing hypertension. AHI is traditionally an important fac-
tor in the diagnosis of OSA, but it does not reflect the total 
apnea/hypopnea duration or O2 desaturation. Thus, compre-
hensive evaluation of polysomnographic data including 
AHIs, apnea/hypopnea duration, and O2 desaturation level 
during sleep should be performed. 
In this study, many factors of clinical and sleep study were 
different between non-HTN and HTN group in OSA pa-
tients. Among them, NC and lowest O2 saturation were 
meaningful factors by multivariate test and we suggest that 
these should be considered in OSA patients. This result 
should allow the clinician to better predict which patients 
with OSA are at higher risk for complications. 
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